0001209191-20-037571.txt : 20200618
0001209191-20-037571.hdr.sgml : 20200618
20200618161656
ACCESSION NUMBER: 0001209191-20-037571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200616
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGUIRE TERRANCE
CENTRAL INDEX KEY: 0001117003
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 20972785
MAIL ADDRESS:
STREET 1: C/O POLARIS VENTURE PARTNERS LP
STREET 2: 1000 WINTER STREET, SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02154
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-16
0
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001117003
MCGUIRE TERRANCE
C/O CYCLERION THERAPEUTICS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
4.46
2020-06-16
4
A
0
10000
0.00
A
2030-06-16
Common Stock
10000
10000
D
The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
/s/ David Slatcher, Attorney-in-Fact
2020-06-18